Understanding the genetic causes of exfoliation glaucoma
Molecular Mechanisms of Exfoliation Glaucoma
This study is looking into how certain genes and proteins in the eye might contribute to exfoliation glaucoma, a condition that can lead to vision loss, to help us understand what causes the increased eye pressure associated with it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10672918 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind exfoliation glaucoma, a condition characterized by protein deposits in the eye that can lead to blindness. The team is exploring how genetic variations in a specific gene region affect the expression of a long non-coding RNA, which may play a crucial role in the disease. By studying the interactions between this RNA and other proteins, the researchers aim to uncover how these molecular changes contribute to increased eye pressure and glaucoma. This work involves advanced techniques such as mass spectrometry and cell culture to analyze gene expression and protein interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with exfoliation glaucoma or those at risk due to genetic factors.
Not a fit: Patients with other forms of glaucoma or unrelated eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential treatments for patients suffering from exfoliation glaucoma.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors in other forms of glaucoma, suggesting that this approach could yield valuable insights.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Hauser, Michael a — Duke University
- Study coordinator: Hauser, Michael a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.